Valuation: SWK Holdings Corporation

Market Cap 19Cr 17Cr 16Cr 14Cr 27Cr 1.83TCr 27Cr 190.93Cr 76Cr 956.57Cr 72Cr 71Cr 3.02TCr P/E 2024
14.7x
P/E 2025 -81.9x
Enterprise Value 18Cr 16Cr 15Cr 13Cr 25Cr 1.67TCr 25Cr 174.93Cr 69Cr 876.44Cr 66Cr 65Cr 2.76TCr EV / Sales 2024
8.06x
EV / Sales 2025 5.11x
Free-Float
96.8%
Yield 2024 *
-
Yield 2025 -
Current year 15.71
Extreme 15.71
17.63
1 year 15.71
Extreme 15.71
17.75
3 years 13.17
Extreme 13.17
20.49
5 years 13.17
Extreme 13.17
20.49
10 years 0
Extreme 0
20.49
Date Insider Type Main position Quantity % Market Cap. Importance
06/04/26
Carlson Capital LP
OthersCompany 3,47,12,035 -
16/06/25 Free

Director

3,858 0.0315%
16/06/25 Free

Director

3,858 0.0315%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-.--%-1.61%+0.06% 19Cr
-1.19%+0.16%+20.95%+149.27% 2.25TCr
-0.11%-0.08%+7.70%+37.87% 1.2TCr
-3.33%-5.18%-20.32%+29.43% 1.1TCr
-3.31%-7.23%-40.49%+3.12% 1.02TCr
+1.43%+2.01%+27.24%+25.44% 878.98Cr
-2.37%-4.50%-21.59%+5.62% 815.38Cr
-1.79%-4.78%+31.37%+73.30% 775.97Cr
Average -1.33%-3.14%+0.41%+40.51% 1.01TCr
Weighted average by Cap. -1.48%-2.01%+2.89%+62.12%

Financials

2024 2025
Net sales 2.75Cr 2.46Cr 2.27Cr 2.06Cr 3.85Cr 261.49Cr 3.92Cr 27Cr 11Cr 137Cr 10Cr 10Cr 431.94Cr 3.76Cr 3.36Cr 3.1Cr 2.81Cr 5.26Cr 356.78Cr 5.34Cr 37Cr 15Cr 186.93Cr 14Cr 14Cr 589.34Cr
Net income 1.35Cr 1.2Cr 1.11Cr 1.01Cr 1.89Cr 128.04Cr 1.92Cr 13Cr 5.3Cr 67Cr 5.06Cr 4.95Cr 211.5Cr -25.33L -22.62L -20.9L -18.94L -35.43L -24Cr -36.01L -2.51Cr -99.55L -13Cr -95.06L -93.04L -40Cr
Net Debt 2.8Cr 2.5Cr 2.31Cr 2.09Cr 3.91Cr 265.33Cr 3.97Cr 28Cr 11Cr 139.01Cr 10Cr 10Cr 438.27Cr -1.61Cr -1.44Cr -1.33Cr -1.2Cr -2.25Cr -152.93Cr -2.29Cr -16Cr -6.33Cr -80Cr -6.05Cr -5.92Cr -252.61Cr
Projected Income Statement - Annual - SWK Holdings Corporation
Logo SWK Holdings Corporation
SWK Holdings Corporation is a life science focused specialty finance company partnering with small- and mid-sized commercial-stage healthcare companies. The Company provides non-dilutive financing to fuel the development and commercialization of lifesaving and life-enhancing medical technologies and products. The Company's solutions include structured debt, traditional royalty monetization, synthetic royalty transactions, and asset purchases typically ranging in size from $5.0 million to $25.0 million.
Employees
9
  1. Stock Market
  2. Stocks
  3. SWKH Stock